Effectiveness of the ECHOs Approach for Patients With Eating Disorders and Their Carers

NCT01927042 | Completed

• 2 other identifiers: 5909300559095003
• Study Type: interventional
• Target: 58
• Locations: 1 country
• Sites: 1

Brief Summary

Family therapy is considered an empirically supported treatment approach for adolescents and adults with eating disorders. One family based approach, Expert Carers Helping Others (ECHO) is based on evidence that suggests family environment, e.g., carer criticism, can influence an individual's eating disorder symptoms. ECHO aims to improve carer coping, reduce expressed emotion and manage eating disorder symptoms, and has been associated with reduced carer distress, caregiver burden, and an increase in general well being. The current pilot study seeks to evaluate a new condensed version of the ECHO intervention that is delivered entirely in a 2 ½ hour self-help DVD format (ECHOs). Sixty patients and their carers will be recruited from the Capital Health Eating Disorders Service and randomized into either a treatment as usual group (TAU) or a TAU+ECHOs group. Both carers and patients will be assessed along a variety of dimensions including psychiatric symptoms, family functioning, and carer and patient collaboration, at pre-intervention, four weeks later at post-intervention, and then three-months post-intervention. ANOVAs will be used to compare the primary outcomes between the two groups over time. This pilot study will be the first evaluation of ECHOs, which may ultimately boost the efficacy of current treatment for adults with eating disorders and reduce carer distress.

Conditions

Eating Disorders

Keywords

Eating Disorders; Carers

Outcome Measures

Primary Outcomes (2)

• Changes in Carer and Patient Collaboration Scale (CPCS).

  A scale to assess self efficacy in caregiving, specifically tailored to measure the skills taught in the ECHOs intervention. This scale will assess changes from baseline to post-internvention in caregiver efficacy.

  baseline, 4-weeks post-intervention, 3 months follow-up

• Changes in Short Evaluation of Eating Disorders (SEED)

  This measure will asssess changes in the severity of key anorexic and bulimic symptoms from baseline to post-treatment, and follow-up.

  baseline, 4-weeks post-intervention, 3 months follow-up

Secondary Outcomes (2)

• Depression, Stress and Anxiety Scale (DASS-21)

  baseline, 4-weeks post-intervention, 3 months follow-up

• The Family Questionnaire (FQ)

  baseline, 4-weeks post-intervention, 3 months follow-up

Study Arms (2)

Expert Cares Helping Others plus Treatment as Usual

EXPERIMENTAL

The experimental treatment (ECHOs plus TAU) will consist of the standard treatment consisting of group psychotherapy and skills training, nutritional counselling, and meal support, PLUS self-help unguided DVD series for carers, providing education about eating disorders and coping strategies for supporting those living with eating disorders.

Behavioral: ECHOs plus TAU

Treatment as Usual

ACTIVE COMPARATOR

Treatment as usual (TAU) consists of group psychotherapy and skills training, nutritional counselling, and meal support.

Behavioral: Treatment as Usual

Interventions

ECHOs plus TAU BEHAVIORAL

A self-help DVD that provides information for carers on eating disorders and teaches coping strategies to carers.

Also known as: Expert Carers Helping Others plus Treatment as Usual

Expert Cares Helping Others plus Treatment as Usual

Treatment as Usual BEHAVIORAL

Treatment as Usual at the Eating Disorder Services includes group psychotherapy and skills training, nutritional counselling, and meal support.

Also known as: TAU

Treatment as Usual

Eligibility Criteria

• Age: 17 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with an ED (AN, BN, EDNOS) according to DSM-V criteria (American Psychiatric Association, 2013) as determined by standard clinical interview completed by team psychiatrist or clinical psychologist.
• Patients age of \>17y.o.
• Carers can include parents/partners/siblings/extended family who provide unpaid help and support. Peers and roommates could also be included in circumstances within which they play a significant role in the person's life and meet the following criteria:
• Live with or have regular, current contact with the patient (at least 7 hours/week) throughout the duration of the trial (approximately 6months).
• Interact with the patient in some meaningful manner regarding their ED (e.g. provide support, eat meals together, discussions about behaviours).
• Consent from patient and at least one carer

You may not qualify if:

• ED comorbid with severe psychiatric or physical comorbidity: e.g. current psychotic illness (inc. bipolar disorder), severe alcohol/drug abuse, significant metabolic or gastrointestinal problems (i.e. treatment interfering) as determined by standard clinical interview completed by team psychiatrist or clinical psychologist.
• Family in a concurrent treatment trial.
• Either patient or carer has insufficient knowledge of English.

Sponsors & Collaborators

• Nova Scotia Health Authority: lead

Study Sites (1)

Capital Health District Health Authority

Halifax, Nova Scotia, B3H2E2, Canada

Location

MeSH Terms

Conditions

Feeding and Eating Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Psychiatrist

Study Record Dates

• First Submitted: August 15, 2013
• First Posted: August 22, 2013
• Study Start: April 1, 2014
• Primary Completion: December 1, 2017
• Study Completion: December 1, 2017
• Last Updated: July 17, 2018

Record last verified: 2018-07

Locations

CA (1)